In vitro metabolism of canagliflozin in human liver, kidney, intestine microsomes, and recombinant uridine diphosphate glucuronosyltransferases (UGT) and the effect of genetic variability of UGT enzymes on the pharmacokinetics of canagliflozin in humans

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 9, 2015-09 ,pp. : 1061-1072

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacogenomics of Human Uridine Diphospho‐Glucuronosyltransferases and Clinical Implications

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 96, Iss. 3, 2014-09 ,pp. : 324-339

John Wiley & Sons Inc

Access to resources Recommend Favorite

UGT1A1, UGT1A6 and UGT1A7 Genetic Analysis: Repercussion for Irinotecan Pharmacogenetics in the São Miguel Island Population (Azores, Portugal)

By Pacheco Paula R.   Brilhante Maria J.   Ballart Cristina   Sigalat Francesc   Polena Helena   Cabral Rita   Branco Claudia C.   Mota-Vieira Luisa  

Molecular Diagnosis & Therapy, Vol. 13, Iss. 4, 2009-08 ,pp. : 261-268

Adis International

Access to resources Recommend Favorite

A Phase I Study of Infusional 5-Fluorouracil, Leucovorin, Oxaliplatin and Irinotecan in Japanese Patients with Advanced Colorectal Cancer Who Harbor UGT1A1*1/*1,*1/*6 or *1/*28

By  

Oncology, Vol. 82, Iss. 4, 2012-04 ,pp. : 242-248

Karger

Access to resources Recommend Favorite

A cross‐sectional clinic‐based study exploring whether variants within the glutathione S‐transferase, haptoglobin and uridine 5′‐diphospho‐glucuronosyltransferase 1A1 genes are associated with interindividual phenotypic variation in sickle cell anaemia in Jamaica

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 100, Iss. 2, 2018-02 ,pp. : 147-153

John Wiley & Sons Inc

Access to resources Recommend Favorite